Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ventyx Biosciences
Biotech
Ventyx lays off 20% of staff after cutting TYK2 indications
After seeing its share price plummet 94% in six months, the inflammatory disease company has decided to reduce its headcount by 20%.
Nick Paul Taylor
Dec 8, 2023 8:45am
Ventyx stock drops 70% as TYK2 inhibitor psoriasis plans halted
Nov 7, 2023 7:23am
Ventyx misses with investors amid comparisons to BMS, Pfizer
Oct 10, 2023 6:30am
Ventyx nabs an upsized IPO to challenge BMS' Zeposia
Oct 21, 2021 9:20am
Ventyx files for $100M IPO to fund 6 or more trials by 2023
Sep 30, 2021 3:30pm
Ventyx picks up $51M, ex-Horizon EVP as chief medical officer
Sep 20, 2021 10:56am